Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility
暂无分享,去创建一个
K. Kadler | R. Iozzo | K. Danielson | D. Holmes | H. Baribault | H. Graham
[1] I. Weber,et al. Model Structure of Decorin and Implications for Collagen Fibrillogenesis* , 1996, The Journal of Biological Chemistry.
[2] J. A. Chapman,et al. Enzymic control of collagen fibril shape. , 1996, Journal of molecular biology.
[3] A. Giordano,et al. Decorin-induced Growth Suppression Is Associated with Up-regulation of p21, an Inhibitor of Cyclin-dependent Kinases* , 1996, The Journal of Biological Chemistry.
[4] E. Zycband,et al. Characterization of collagen fibril segments from chicken embryo cornea, dermis and tendon. , 1996, Matrix biology : journal of the International Society for Matrix Biology.
[5] P. Byers,et al. A translocation interrupts the COL5A1 gene in a patient with Ehlers–Danlos syndrome and hypomelanosis of Ito , 1996, Nature Genetics.
[6] J. Yates,et al. The gene encoding collagen alpha1(V)(COL5A1) is linked to mixed Ehlers-Danlos syndrome type I/II. , 1996, The Journal of investigative dermatology.
[7] J. A. Chapman,et al. Collagen fibril formation. , 1996, The Biochemical journal.
[8] R. Iozzo,et al. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] D. Holmes. Mass mapping of extracellular matrix assemblies. , 1995, Biochemical Society transactions.
[10] M. Young,et al. Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. , 1995, Acta orthopaedica Scandinavica. Supplementum.
[11] Oldberg,et al. Decorin-binding Sites for Collagen Type I Are Mainly Located in Leucine-rich Repeats 4-5 (*) , 1995, The Journal of Biological Chemistry.
[12] Paul Wordsworth,et al. Linkage of the gene that encodes the alpha 1 chain of type V collagen (COL5A1) to type II Ehlers-Danlos syndrome (EDS II). , 1995, Human molecular genetics.
[13] T Skorski,et al. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] T. Rosenquist,et al. Expression of collagens and decorin during aortic arch artery development: implications for matrix pattern formation. , 1995, Matrix biology : journal of the International Society for Matrix Biology.
[15] E. Schönherr,et al. Decorin-Type I Collagen Interaction , 1995, The Journal of Biological Chemistry.
[16] J. Deisenhofer,et al. A structural basis of the interactions between leucine-rich repeats and protein ligands , 1995, Nature.
[17] E. Zycband,et al. Collagen fibrillogenesis in situ: Fibril segments undergo post‐depositional modifications resulting in linear and lateral growth during matrix development , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.
[18] R. Iozzo,et al. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. , 1994, Genes & development.
[19] L. Siracusa,et al. The murine decorin. Complete cDNA cloning, genomic organization, chromosomal assignment, and expression during organogenesis and tissue differentiation. , 1994, The Journal of biological chemistry.
[20] P. Byers. Ehlers-Danlos syndrome: recent advances and current understanding of the clinical and genetic heterogeneity. , 1994, The Journal of investigative dermatology.
[21] E. Ruoslahti,et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. , 1994, The Biochemical journal.
[22] J. Gallagher. Dermatan sulphate proteoglycans: edited by J. E. Scott, Portland Press, 1993. £75.00 (374 pages) ISBN 1 85578 0518 , 1994 .
[23] J. A. Chapman,et al. Vertebrate (chick) collagen fibrils formed in vivo can exhibit a reversal in molecular polarity. , 1994, Journal of molecular biology.
[24] M. Seashore,et al. Dermatosparaxis in children. A case report and review of the newly recognized phenotype. , 1993, Archives of dermatology.
[25] J. Roder,et al. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[26] K. Kadler. Learning how mutations in type I collagen genes cause connective tissue disease. , 1993, International journal of experimental pathology.
[27] K. Kadler,et al. Ehlers-Danlos syndrome type VIIB. Morphology of type I collagen fibrils formed in vivo and in vitro is determined by the conformation of the retained N-propeptide. , 1993, The Journal of biological chemistry.
[28] H. Baribault,et al. Mid-gestational lethality in mice lacking keratin 8. , 1993, Genes & development.
[29] J. Hassell,et al. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. , 1993, Experimental eye research.
[30] L. Culp,et al. Differences in decorin expression by papillary and reticular fibroblasts in vivo and in vitro. , 1993, The Biochemical journal.
[31] J. Volanakis,et al. The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. , 1992, Journal of immunology.
[32] K. Vogel,et al. The interaction of decorin core protein fragments with type I collagen. , 1992, Biochemical and biophysical research communications.
[33] J. A. Chapman,et al. Growing tips of type I collagen fibrils formed in vitro are near-paraboloidal in shape, implying a reciprocal relationship between accretion and diameter. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Seashore,et al. Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen. , 1992, American journal of human genetics.
[35] D. Birk,et al. beta-D xyloside alters dermatan sulfate proteoglycan synthesis and the organization of the developing avian corneal stroma. , 1992, Development.
[36] A. Paepe,et al. Evidence for a relationship between Ehlers–Danlos type VII C in humans and bovine dermatosparaxis , 1992, Nature Genetics.
[37] P. Byers,et al. Ehlers Danlos syndrome type VIIB. Incomplete cleavage of abnormal type I procollagen by N-proteinase in vitro results in the formation of copolymers of collagen and partially cleaved pNcollagen that are near circular in cross-section. , 1992, The Journal of biological chemistry.
[38] R. Timpl,et al. Binding of the proteoglycan decorin to collagen type VI. , 1992, The Journal of biological chemistry.
[39] H. Baribault,et al. Polarized and functional epithelia can form after the targeted inactivation of both mouse keratin 8 alleles , 1991, The Journal of cell biology.
[40] J. A. Chapman,et al. Morphology of sheet-like assemblies of pN-collagen, pC-collagen and procollagen studied by scanning transmission electron microscopy mass measurements. , 1991, Journal of molecular biology.
[41] Allan Bradley,et al. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice , 1991, Cell.
[42] T. Yagi,et al. Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diphtheria toxin A-fragment gene in negative selection. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[43] G. Pringle,et al. Immunoelectron microscopic localization of the core protein of decorin near the d and e bands of tendon collagen fibrils by use of monoclonal antibodies. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[44] K. Kadler,et al. Collagen fibrils in vitro grow from pointed tips in the C- to N-terminal direction. , 1990, The Biochemical journal.
[45] K. Doane,et al. Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. , 1990, Journal of cell science.
[46] R. Iozzo,et al. Bovine pericardial proteoglycan: biochemical, immunochemical and ultrastructural studies. , 1989, Matrix.
[47] J. Scott. Proteoglycan-fibrillar collagen interactions. , 1988, The Biochemical journal.
[48] T. Koob,et al. Characterization and interactions of a fragment of the core protein of the small proteoglycan (PGII) from bovine tendon. , 1987, Biochemical and biophysical research communications.
[49] V. Nolte,et al. Interaction of small dermatan sulfate proteoglycan from fibroblasts with fibronectin , 1987, The Journal of cell biology.
[50] J. Trotter,et al. The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. , 1987, Collagen and related research.
[51] B. Nusgens,et al. Acidic glycosaminoglycans, isolation and structural analysis of a proteodermatan sulfate from dermatosparactic calf skin. , 1987, Collagen and related research.
[52] P. Scott,et al. A role for disulphide bridges in the protein core in the interaction of proteodermatan sulphate and collagen. , 1986, Biochemical and biophysical research communications.
[53] J. Ramshaw,et al. A morphologic study of a mild form of ovine dermatosparaxis. , 1985, The Journal of investigative dermatology.
[54] R. Haut. The effect of a lathyritic diet on the sensitivity of tendon to strain rate. , 1985, Journal of biomechanical engineering.
[55] D. Heinegård,et al. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. , 1984, The Biochemical journal.
[56] R. Iozzo. Biosynthesis of heparan sulfate proteoglycan by human colon carcinoma cells and its localization at the cell surface , 1984, The Journal of cell biology.
[57] R. Trelstad. Multistep assembly of type I collagen fibrils , 1982, Cell.
[58] D. Nelson,et al. Ehlers-Danlos syndrome type VIII. , 1981, Journal of the American Academy of Dermatology.
[59] J. Scott,et al. Dermatan sulphate-rich proteoglycan associates with rat tail-tendon collagen at the d band in the gap region. , 1981, The Biochemical journal.
[60] P. Byers,et al. Dermatosparaxis in a Himalayan cat: I. Biochemical studies of dermal collagen. , 1980, The Journal of investigative dermatology.
[61] P. Byers,et al. Defect in Conversion of Procollagen to Collagen in a Form of Ehlers-Danlos Syndrome , 1973, Science.
[62] B. Toole,et al. The effect of chondroitin sulphate-protein on the formation of collagen fibrils in vitro. , 1968, The Biochemical journal.
[63] B. Toole,et al. The organisation of hexosamine-containing compounds in bovine skin. , 1966, Biochimica et biophysica acta.
[64] B. Rigby. Effect of Cyclic Extension on the Physical Properties of Tendon Collagen and its Possible Relation to Biological Ageing of Collagen , 1964, Nature.
[65] D J Prockop,et al. Collagens: molecular biology, diseases, and potentials for therapy. , 1995, Annual review of biochemistry.
[66] R. Jaenisch,et al. Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly , 1995, Nature Genetics.
[67] R. Castelein. The Netherlands Orthopedic Society Utrecht, October 8, 1994 , 1995 .
[68] R. Haut,et al. Correlation of high-speed tensile strength with collagen content in control and lathyritic rat skin. , 1993, The Journal of surgical research.
[69] J. Scott,et al. Proteoglycan: collagen interactions in dermatosparactic skin and tendon. An electron histochemical study using cupromeronic blue in a critical electrolyte concentration method. , 1989, Matrix.
[70] F H Silver,et al. Mechanical properties of collagen fibres: a comparison of reconstituted and rat tail tendon fibres. , 1989, Biomaterials.
[71] K. Vogel,et al. Characteristics of the in vitro interaction of a small proteoglycan (PG II) of bovine tendon with type I collagen. , 1989, Matrix.